SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is generating significant buzz from its CES keynote, where CEO Lisa Su is highlighting groundbreaking advancements like the MI500 series promising 1000x AI performance by 2027 and new Ryzen AI processors for various industries. The community is praising AMD's robust product pipeline and strategic partnerships, seeing the company as a credible and substantive leader in the evolving AI and high-performance computing landscape.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is gaining significant attention due to its GPS immunotherapy, with community discussion centered on the unexpected longevity of patients in its ongoing AML trial, signaling strong efficacy and a potential paradigm shift in cancer treatment. Investors are actively debating a substantial revaluation and the strong likelihood of a competitive buyout, fueled by the drug's promising performance and a belief that short positions are increasingly vulnerable amidst high borrow fees and limited share availability.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending with strong community engagement, largely fueled by a vibrant ecosystem of memecoins, notably $WEEDCOIN, which are driving significant conversation and perceived liquidity. Users are actively discussing Solana's price potential and its role in an anticipated altcoin market expansion, often highlighting its efficiency as a layer-one network.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending after its CES keynote introduced the Vera Rubin AI platform, now in full production, and emphasized its strategy to deliver complete AI supercomputer stacks, accelerating the push into physical AI, robotics, and autonomous vehicles. The community is buzzing with excitement over these future-forward initiatives and NVIDIA's continued innovation, though some investors debate whether current market valuations fully reflect these long-term growth prospects.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as market sentiment weighs the impact of increased competition from a recently launched oral GLP-1, sparking concerns over pricing and market share in the obesity space. Despite the pressure, the community remains divided, with many emphasizing VKTX's robust clinical data and upcoming catalysts like the J.P. Morgan Conference and potential FDA updates on its oral program. Optimism persists for a potential strategic partnership or acquisition, fueling ongoing debates around executive stock sales and the company's long-term value in a rapidly evolving market.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

WEEDCOIN is trending due to community excitement surrounding political tailwinds, particularly discussions about cannabis rescheduling and potential tax reform, which are seen as catalysts for fundamental growth. The community actively promotes WEEDCOIN as the 'Green Wave' and a significant liquidity driver within the Solana ecosystem, advocating for biological sovereignty and challenging traditional pharmaceutical narratives. Holders emphasize long-term commitment and cultural alignment, rallying under the slogan 'Like Bitcoin But Way Higher'.

Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company, which engages in the development and commercialization of transformative immunology-based therapies for patients. The company was founded by Lonnie O. Moulder Jr on November 12, 2019 and is headquartered in Waltham, MA.

Zenas Biopharma Inc.

Zenas BioPharma is trending after its Phase 3 trial results for obexelimab, which, despite meeting primary endpoints, triggered a substantial stock decline. The market's sharp reaction appears driven by perceptions of the drug's efficacy falling short of competitor treatments and the impact on milestone payments. This has ignited community debate, with many viewing the stock as deeply oversold and a potential bounce play against significant short interest.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is a hot topic amidst widespread community discussions about an "altcoin season" and general crypto market growth, propelled by hopes for the "Clarity Act" and potential future rate adjustments. The conversation centers on its technical developments like LitVM and Drivechains, paired with diminishing supply, contrasting with debates about its performance compared to other major cryptocurrencies.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is trending following its strategic collaboration with OpenAI to power its Athena marketing platform, sparking immense community enthusiasm and a surge in trading volume. Many market participants view ZETA as significantly undervalued for an AI-leveraged Martech company, anticipating a substantial re-rating and further catalysts as it approaches CES 2026.

Aeva Technologies, Inc. develops sensing paradigm for autonomous vehicles and robotics. The firm offers drones, robotics, vehicle technology, and virtual and augmented reality products. The company was founded by Soroush Salehian Dardashti and Mina Rezk in 2017 and is headquartered in Mountain View, CA.

Aeva Technologies Inc

Aeva Technologies is surging following news of its 4D LiDAR being selected for integration into the NVIDIA DRIVE Hyperion Platform, sparking widespread community excitement. Investors are bullish, anticipating a significant short squeeze due to high short interest, with many eyeing substantial price targets. This strategic partnership firmly positions the LiDAR innovator at the center of autonomous driving and physical AI discussions, despite some caution regarding long-term revenue timelines.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives Consensus Rating of "Buy" from Analysts

Aquestive Therapeutics, Inc. (NASDAQ:AQST - Get Free Report) has received an average rating of "Buy" from the ten ratings firms that are presently covering the company, Marketbeat.com reports. One...

Aquestive Therapeutics (NASDAQ:AQST) Shares Up 5.7% - Should You Buy?

Aquestive Therapeutics (NASDAQ:AQST) Trading 5.7% Higher - Here's Why...

Aquestive Therapeutics (NASDAQ:AQST) Trading Down 4.6% - What's Next?

Aquestive Therapeutics (NASDAQ:AQST) Trading Down 4.6% - Here's What Happened...

Diametric Capital LP Acquires Shares of 165,373 Aquestive Therapeutics, Inc. $AQST

Diametric Capital LP bought a new stake in Aquestive Therapeutics, Inc. (NASDAQ:AQST - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange...

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives Consensus Recommendation of "Buy" from Brokerages

Aquestive Therapeutics, Inc. (NASDAQ:AQST - Get Free Report) has earned a consensus rating of "Buy" from the eleven analysts that are covering the stock, MarketBeat Ratings reports. One equities...

Everstar Asset Management LLC Raises Holdings in Aquestive Therapeutics, Inc. $AQST

Everstar Asset Management LLC increased its position in Aquestive Therapeutics, Inc. (NASDAQ:AQST - Free Report) by 119.5% in the 2nd quarter, according to the company in its most recent filing with...

Aquestive Therapeutics (NASDAQ:AQST) Sees Unusually-High Trading Volume - Here's Why

Aquestive Therapeutics (NASDAQ:AQST) Sees Unusually-High Trading Volume - Here's Why...

Aquestive Therapeutics (NASDAQ:AQST) Trading Up 6.5% - Here's Why

Aquestive Therapeutics (NASDAQ:AQST) Stock Price Up 6.5% - Here's What Happened...

Leerink Partnrs Has Pessimistic View of AQST Q4 Earnings

Aquestive Therapeutics, Inc. (NASDAQ:AQST - Free Report) - Research analysts at Leerink Partnrs dropped their Q4 2025 EPS estimates for shares of Aquestive Therapeutics in a research report issued on...

HC Wainwright Has Pessimistic View of AQST FY2025 Earnings

Aquestive Therapeutics, Inc. (NASDAQ:AQST - Free Report) - Equities research analysts at HC Wainwright decreased their FY2025 EPS estimates for shares of Aquestive Therapeutics in a research note...

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

Aquestive Therapeutics Inc

Physical AI Infrastructure

Power & Energy to Support Growth

Healthcare Value & Innovation

Other – Comment Below

As markets head into 2026, investors are debating whether the next phase favors speculation or real-world execution. With capital rotating toward infrastructure, energy, and undervalued sectors like healthcare, which area do you think will matter most for portfolios in the year ahead?

Which Theme Will Matter Most for Portfolios in 2026?

Current Price	$6.23
Prev Close	$6.45
Open	$6.46
Dividend Yield	0.00%
50-Day Moving Average	$6.13
Beta	1.30
Avg. Volume	2.27M
PE Ratio	-8.86

52-Week High	$7.55
52-Week Low	$2.12
Market Capitalization	$786.92M
EPS (Annual)	-$0.5089
Price to Book	-184.48
Revenue Per Employee	$405,359.16
Enterprise Value/EBITDA	N/A

AQST
Aquestive Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AQST News

AQSTAquestive Therapeutics Inc